There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on scPharmaceuticals (SCPH – Research Report), Adicet Bio (ACET – Research Report) and MiNK Therapeutics (INKT – Research Report) with bullish sentiments.
scPharmaceuticals (SCPH)
In a report released yesterday, Naz Rahman from Maxim Group maintained a Buy rating on scPharmaceuticals, with a price target of $10.00. The company’s shares closed last Wednesday at $5.82.
According to TipRanks.com, Rahman has 0 stars on 0-5 stars ranking scale with an average return of
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for scPharmaceuticals with a $10.33 average price target.
See the top stocks recommended by analysts >>
Adicet Bio (ACET)
H.C. Wainwright analyst Edward White reiterated a Buy rating on Adicet Bio today and set a price target of $34.00. The company’s shares closed last Wednesday at $17.95.
According to TipRanks.com, White has 0 stars on 0-5 stars ranking scale with an average return of
Currently, the analyst consensus on Adicet Bio is a Strong Buy with an average price target of $28.50.
MiNK Therapeutics (INKT)
H.C. Wainwright analyst Emily Bodnar initiated coverage with a Buy rating on MiNK Therapeutics today and set a price target of $7.00. The company’s shares closed last Wednesday at $1.33, close to its 52-week low of $1.09.
According to TipRanks.com, Bodnar is a 3-star analyst with an average return of
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for MiNK Therapeutics with a $7.00 average price target.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Read More on SCPH:
- Analysts Offer Insights on Healthcare Companies: VYNE Therapeutics (VYNE) and MiNK Therapeutics (INKT)
- Grove, Inc. to Present at Sidoti August Microcap Conference
- A.I.S. Resources Amends Terms of Bright Gold Project Agreement
- CSX Executive Vice President of Sales & Marketing to Address Deutsche Bank Transportation Conference
- Toni-Ann Mills Joins Precipio’s Products Division to Lead Channel Partner Training, Learning & Development
